Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News MorphoSys 4 ADR Representing Ord Shs MOR

Alternate Symbol(s):  MPHSF | MPSYF

Healthcare Technology Biotechnology Scientific & Technical Instruments
MorphoSys AG is a global commercial-stage biopharmaceutical company based in Germany. The Company discovers, develops, and delivers cancer medicines to patients. It markets its proprietary medicine Monjuvi (tafasitamab-cxix) in the United States, a cancer immunotherapy treatment, used to treat patients in combination with lenalidomide with second and later lines of diffuse large B-cell lymphoma... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:MOR)

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BEST, MOR, HCP, SQSP on Behalf of Shareholders

PR Newswire 1 day ago

MOR STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of MorphoSys AG Is Fair to Shareholders

Business Wire 1 day ago

MorphoSys and Novartis Sign Delisting Agreement and Intend to Implement a Merger Squeeze-out of MorphoSys' Minority Shareholders

Business Wire 2 days ago

Ad hoc: Novartis BidCo Germany AG Intends to Implement a Merger Squeeze-out of MorphoSys AG's Minority Shareholders

Accesswire 2 days ago

MorphoSys AG Reports First Quarter 2024 Financial Results

Business Wire April 29, 2024

MorphoSys To Present New Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2024 ASCO Annual Meeting

Accesswire April 24, 2024

MorphoSys' Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by Novartis

Business Wire April 11, 2024

MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act

Accesswire March 22, 2024

MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Business Wire March 13, 2024
View More News ››

Opinion & Analysis (NDAQ:MOR)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:MOR)

(MOR) Pivots Trading Plans and Risk Controls

News; $MOR (MOR) Pivots Trading Plans and Risk Controls2024-06-15 22:54:00 ET Stock Traders Daily has produced this trading report using...
whytestocks - 6 days ago

MorphoSys AG Reports First Quarter 2024 Financial Results

Just In: $MOR MorphoSys AG Reports First Quarter 2024 Financial Results@ Entered into Business Combination Agreement to be acquired by...
whytestocks - April 29, 2024

MorphoSys Stock Soars After Report Says Novartis To Acquire

Breaking News: $MOR MorphoSys Stock Soars After Report Says Novartis To Acquire Cancer-Drug Developer | BenzingaMorphoSys AG (NASDAQ:MOR...
whytestocks - February 5, 2024

MorphoSys AG (NASDAQ: MOR) Near the Top of Equities by Perce

JUST IN: $MOR MorphoSys AG (NASDAQ: MOR) Near the Top of Equities by Percentage Gain on 2/5MorphoSys AG (NASDAQ: MOR) is one of today...
whytestocks - February 5, 2024

MorphoSys Reports Preliminary 2023 Monjuvi U.S. Net Product

Just In: $MOR MorphoSys Reports Preliminary 2023 Monjuvi U.S. Net Product Sales and Gross Margin, Provides 2024 Financial Guidance and...
whytestocks - January 30, 2024

Real stock price share value

13$
Nibinator - October 30, 2023
View more Bullboard ››

Acceleware Ltd

Acceleware Ltd

Acceleware Ltd. is a Canada-based company that develops clean-tech decarbonization technologies. The Company has two business ...
View More »